Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FK13H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,180
Award facts
- Contract value 100% obligated
- $23,180.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,180.46 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick prefilled syringes. This competitively awarded, firm fixed-price contract was issued on May 8, 2025, with an ultimate completion date of May 9, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills the DLA's medical supply requirements across multiple therapeutic domains, including specialty medications, biologics, and injectable pharmaceuticals. Enbrel, a biologic disease-modifying antirheumatic drug used primarily for treating autoimmune conditions, represents the type of specialized pharmaceutical product the company routinely supplies to support military healthcare programs and defense health systems. The SPE2DX master contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FK13H?
SPE2DB25FK13H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FK13H worth?
The government has obligated $23,180 on SPE2DB25FK13H.
Is contract SPE2DB25FK13H an order under another contract?
Yes. SPE2DB25FK13H is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK13H competed?
The extent of competition for SPE2DB25FK13H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award